
2025 ACC statement: inflammation in ASCVD is compelling and clinically actionable
The American College of Cardiology's scientific statement says the evidence linking inflammation with atherosclerotic CVD is no longer exploratory, and provides consensus recommendations for evaluation, treatment and prevention. hsCRP is highlighted as a key marker of residual inflammatory risk.






